Startup details


Theresa Kit – a brand new innovative in vitro diagnostic tool

Short summary

Increasing population is suffering from inflammatory diseases and gold-standard small molecule immunomodulatory therapies turn out to be ineffective for about 30% of patients within 1 year of treatment initiation. Early identification of non-responders by means of a diagnostic test is crucial to avoid ineffective therapies. Teresa kit is a precision diagnostic tool for quantifying patients’ inherent risk for observing therapeutic resistance driven by the activity of multidrug transporter (MDR) proteins. We, scientists at Navolab Diagnostics believe that applying Theresa kit in the diagnostic panel of patients with inflammatory disorders like pneumonia or IBD makes their medical care more patient centric and renders it highly cost-effective.